AIM
ASXC

Acrospire Investment Management’s Asensus Surgical, Inc. ASXC Stock Holding History

Acrospire Investment Management’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-914
Closed -$15K – 2557
2016
Q4 		$15K Buy
914
+561
+159% +$11.5K 0.01% 1863
2016
Q3 		$8K Buy
+353
New +$6.45K 0.01% 1758

Other funds holding ASXC

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IBT
International Biotechnology Trust London, United Kingdom $297M AUM 17.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Acrospire Investment Management's ASXC Position: Q1 2017 in Review

Acrospire Investment Management sold out of Asensus Surgical, Inc. (ASXC) in Q1 2017, closing a stake of 914 shares — an estimated $15K sold.

Acrospire Investment Management first reported a position in ASXC in Q3 2016 and held it in 2 quarters. The position peaked at $15K in Q4 2016. 80 funds tracked by Wall St. Rank hold ASXC as of Q1 2017.

  • Acrospire Investment Management reported no remaining Asensus Surgical, Inc. position as of Q1 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 914 Asensus Surgical, Inc. shares in Q1 2017, an estimated $15K.
  • Acrospire Investment Management first reported a position in Asensus Surgical, Inc. in Q3 2016 and held it in 2 quarters.
  • Acrospire Investment Management's Asensus Surgical, Inc. position peaked at $15K in Q4 2016.
  • 80 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q1 2017.

Based on Acrospire Investment Management's 13F filing for Q1 2017, filed 4 May 2017.